Form 4: Moderna's Chief Legal Officer Shannon Thyme Klinger Reports Stock Transactions
SEC Form 4 Filing
Shannon Thyme Klinger, Moderna's Chief Legal Officer, reported the acquisition of 328 shares and the sale of 183 shares to cover tax obligations.
Summary
- On May 28, 2024, Shannon Thyme Klinger, Chief Legal Officer of Moderna, acquired 328 shares of common stock upon the vesting of restricted stock units.
- On May 29, 2024, Ms. Klinger sold 183 shares of common stock at a price of $144.5047 per share to cover tax withholding obligations related to the vesting of restricted stock units.
- Following these transactions, Ms. Klinger directly owns 10,768 shares of Moderna common stock.
- Ms. Klinger also directly owns 3,617 restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock transactions by an officer, and it doesn't inherently indicate positive or negative sentiment. The transactions are related to compensation and tax obligations.
Industry Context
This Form 4 filing is a routine disclosure related to stock transactions by a company insider, and such filings are common for publicly traded companies like Moderna. It provides transparency into the trading activities of key personnel.
Key Dates
| Date | Description |
|---|---|
| 05/28/2024 | Acquisition of 328 shares of common stock through vesting of restricted stock units. |
| 05/29/2024 | Sale of 183 shares of common stock at $144.5047 to cover tax obligations. |
| 05/30/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.